These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 17085653

  • 21. Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer.
    Mita K, Zhang Z, Ando Y, Toyama T, Hamaguchi M, Kobayashi S, Hayashi S, Fujii Y, Iwase H, Yamashita H.
    Jpn J Clin Oncol; 2007 Aug; 37(8):575-82. PubMed ID: 17675285
    [Abstract] [Full Text] [Related]

  • 22. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
    Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440
    [Abstract] [Full Text] [Related]

  • 23. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618
    [Abstract] [Full Text] [Related]

  • 24. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S, Tada M, Hida Y, Asano T, Kuramae T, Takemoto N, Hamada J, Miyamoto M, Hirano S, Kondo S, Moriuchi T.
    J Surg Res; 2008 May 01; 146(1):104-9. PubMed ID: 17663001
    [Abstract] [Full Text] [Related]

  • 25. Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Tsukiyama A, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
    Mod Pathol; 2003 Apr 01; 16(4):309-14. PubMed ID: 12692195
    [Abstract] [Full Text] [Related]

  • 26. Overexpression of HRad17 mRNA in human breast cancer: correlation with lymph node metastasis.
    Kataoka A, Sadanaga N, Mimori K, Ueo H, Barnard GF, Sugimachi K, Auclair D, Chen LB, Mori M.
    Clin Cancer Res; 2001 Sep 01; 7(9):2815-20. PubMed ID: 11555598
    [Abstract] [Full Text] [Related]

  • 27. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
    Zhang Z, Yamashita H, Toyama T, Omoto Y, Sugiura H, Hara Y, Wu X, Kobayashi S, Iwase H.
    Breast Cancer Res; 2003 Sep 01; 5(6):R250-6. PubMed ID: 14580261
    [Abstract] [Full Text] [Related]

  • 28. p95HER-2 predicts worse outcome in patients with HER-2-positive breast cancer.
    Sáez R, Molina MA, Ramsey EE, Rojo F, Keenan EJ, Albanell J, Lluch A, García-Conde J, Baselga J, Clinton GM.
    Clin Cancer Res; 2006 Jan 15; 12(2):424-31. PubMed ID: 16428482
    [Abstract] [Full Text] [Related]

  • 29. Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer.
    Tong D, Czerwenka K, Heinze G, Ryffel M, Schuster E, Witt A, Leodolter S, Zeillinger R.
    Clin Cancer Res; 2006 Apr 15; 12(8):2442-8. PubMed ID: 16638850
    [Abstract] [Full Text] [Related]

  • 30. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M, Reed MJ, Al Sarakbi W, Jiang WG, Mokbel K.
    Breast Cancer Res Treat; 2006 Sep 15; 99(2):155-62. PubMed ID: 16541304
    [Abstract] [Full Text] [Related]

  • 31. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
    Li BJ, Wang JY, Wang HY, Huang XP, Zhang LJ, Long H, Yang MT, Rong TH.
    Zhonghua Zhong Liu Za Zhi; 2006 Oct 15; 28(10):766-9. PubMed ID: 17366790
    [Abstract] [Full Text] [Related]

  • 32. Significance of skp2 expression in primary breast cancer.
    Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M.
    Clin Cancer Res; 2006 Feb 15; 12(4):1215-20. PubMed ID: 16489076
    [Abstract] [Full Text] [Related]

  • 33. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.
    Span PN, Waanders E, Manders P, Heuvel JJ, Foekens JA, Watson MA, Beex LV, Sweep FC.
    J Clin Oncol; 2004 Feb 15; 22(4):691-8. PubMed ID: 14966093
    [Abstract] [Full Text] [Related]

  • 34. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [Abstract] [Full Text] [Related]

  • 35. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
    Nimmrich I, Sieuwerts AM, Meijer-van Gelder ME, Schwope I, Bolt-de Vries J, Harbeck N, Koenig T, Hartmann O, Kluth A, Dietrich D, Magdolen V, Portengen H, Look MP, Klijn JG, Lesche R, Schmitt M, Maier S, Foekens JA, Martens JW.
    Breast Cancer Res Treat; 2008 Oct 01; 111(3):429-37. PubMed ID: 17965955
    [Abstract] [Full Text] [Related]

  • 36. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.
    Ann Surg Oncol; 2009 Sep 01; 16(9):2494-501. PubMed ID: 19526206
    [Abstract] [Full Text] [Related]

  • 37. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
    Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL.
    Clin Cancer Res; 2003 Feb 01; 9(2):594-600. PubMed ID: 12576423
    [Abstract] [Full Text] [Related]

  • 38. Increased expression of osteopontin in patients with triple-negative breast cancer.
    Wang X, Chao L, Ma G, Chen L, Tian B, Zang Y, Sun J.
    Eur J Clin Invest; 2008 Jun 01; 38(6):438-46. PubMed ID: 18452545
    [Abstract] [Full Text] [Related]

  • 39. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
    Al Sarakbi W, Mokbel R, Salhab M, Jiang WG, Reed MJ, Mokbel K.
    Anticancer Res; 2006 Jun 01; 26(6C):4985-90. PubMed ID: 17214375
    [Abstract] [Full Text] [Related]

  • 40. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y, Yao L, Li H, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Larsson O, Xie Y.
    Breast Cancer Res Treat; 2006 May 01; 97(1):49-55. PubMed ID: 16319978
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.